https://pjicm.com/ojs/index.php/home <p>Articles for Pakistan Journal of Intensive Care Medicine (eISSN: 2789-2905; pISSN: 2789-2891) must be original reports of research not simultaneously submitted to or previously published in any other scientific or technical journal and must make a significant contribution to the advancement of knowledge or toward a better understanding of existing scientific concepts. The study reported should be applicable to a sizable geographic area or an area of ecological or economic significance and of potential interest to a significant number of scientists. Each calendar year will have one volume. PJICM publishes articles as soon as the final copy-edited version is approved by the authors rather than waiting for a collection of articles for a specific issue. Also, each article is published in its respective category (editorial, review, original or commentary). As a result, the page numbers in the ‘Table of Contents’ displayed for each issue will reflect this rather than numerical order. The journal aims to provide a platform of publications under the banner of <em>Med</em>EYE following eminent standards to the researchers, scholars, scientists and professionals of Biological and Medical Sciences. Inclusion of multiple academic disciplines helps in pooling the knowledge from two or more fields of study to handle better suited problems by finding solutions established on new understandings. The authors can submit manuscripts online through OJS. Authors can submit their manuscripts to editorial office along with any query through email at, <a href="mailto:editorbcsrj@gmail.com">editorpjicm@gmail.com.</a></p> en-US submit@pjicm.com (Asim Rana) editorpjicm@gmail.com (Ali Hussain) Sat, 30 Apr 2022 23:28:16 +0000 OJS 3.2.1.2 http://blogs.law.harvard.edu/tech/rss 60 https://pjicm.com/ojs/index.php/home/article/view/10 <p><em>COVID-19 Sars Co V2 or Corona Virus disease is a highly infectious multisystem disease with severe acute lung injury leading to ARDS and respiratory failure as its main complication. Spontaneous pneumothorax is a complication which is though uncommon but could be life threatening and hence carries poor prognosis. We hereby describe a series of six cases of spontaneous pneumothorax which were seen in Bahria International Hospital COVID management unit during last 3 months of COVID-19 surge in Lahore These cases indicate that multiple factors are associated with development of spontaneous pneumothorax in COVID-19 pneumonia patients but main role is played by the increased inflammatory response and can be regarded as a potential underlying mechanism of pneumothorax in such patients, leading to acute decompensation and worsening of respiratory failure and poor outcome.</em></p> R PERVAIZ, T BIBI, B ARIF, A MUNAWAR, R SITARA, MA QAYYUM, A RAZA, A SHAHPER, MM HAFEEZ Copyright (c) 2022 R PERVAIZ, T BIBI, B ARIF, A MUNAWAR, R SITARA, MA QAYYUM, A RAZA, A SHAHPER, MM HAFEEZ https://creativecommons.org/licenses/by-nc/4.0 https://pjicm.com/ojs/index.php/home/article/view/10 Sat, 30 Apr 2022 00:00:00 +0000 https://pjicm.com/ojs/index.php/home/article/view/11 <p>To determine the incidence rate of seborrheic dermatitis, bullous pemphigoid, rosacea, and melanoma among the patients diagnosed with Parkinson's Disease. A cross-sectional, observational study. From 13^thMay 2020 to 13^thApril 2022 at Bahria International Hospital, Lahore, Pakistan. A total of 80 patients with confirmed Parkinson's disease were evaluated for skin disorders. Disease severity was confirmed through Hoehn Yahr staging criteria (H-Y stage). Skin characteristics and disease diagnosis was made through finding sebum production levels, hot/cold flush test, immunofluorescence, and biopsy evaluation for seborrheic dermatitis, rosacea, bullous pemphigoid, and melanoma, respectively. The test results were compared with the control subject. Chi²and student t-test was used to find the significance of the results. Out of 80, 44 patients were positive for skin disorders. The incidence of seborrheic dermatitis was found in 31.2% of patients whereas rosacea, bullous pemphigoid, and melanoma were found in 15%, 6.2%, and 2.5% of patients, respectively. Skin disorders are highly prevalent among Parkinson’s disease patients than in the control population. The study invites further research in this area so that the quality of life of patients could be improved.</p> MR PERVAIZ, N GULL, SMA MERCHANT, B ARIF, A NAZ, M WAHEED, S RAZA, S TAJ, I ALI Copyright (c) 2022 MR PERVAIZ, N GULL, SMA MERCHANT, B ARIF, A NAZ, M WAHEED, S RAZA, S TAJ, I ALI https://creativecommons.org/licenses/by-nc/4.0 https://pjicm.com/ojs/index.php/home/article/view/11 Wed, 01 Jun 2022 00:00:00 +0000